134 related articles for article (PubMed ID: 24398760)
1. Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma.
Ma C; Li Y; Zhang X; Zhao G; Xu H
J Int Med Res; 2014 Feb; 42(1):198-204. PubMed ID: 24398760
[TBL] [Abstract][Full Text] [Related]
2. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Notch1, MMP-2 and MMP-9 and their significance in glioma patients].
Sun ZF; Wang L; Gu F; Fu L; Li WL; Ma YJ
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):26-30. PubMed ID: 22490851
[TBL] [Abstract][Full Text] [Related]
4. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
5. Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas.
Cao WD; Kawai N; Miyake K; Zhang X; Fei Z; Tamiya T
Brain Tumor Pathol; 2014 Jan; 31(1):1-10. PubMed ID: 23358800
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
7. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.
Wang M; Wang T; Liu S; Yoshida D; Teramoto A
Brain Tumor Pathol; 2003; 20(2):65-72. PubMed ID: 14756443
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
9. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells.
Rooprai HK; Rucklidge GJ; Panou C; Pilkington GJ
Br J Cancer; 2000 Jan; 82(1):52-5. PubMed ID: 10638966
[TBL] [Abstract][Full Text] [Related]
10. [Expression of VEGF and NGF in gliomas of human].
Li JT; Yan Q; Yu HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):408-11. PubMed ID: 19626992
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
[TBL] [Abstract][Full Text] [Related]
13. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
14. Loss of pigment epithelium derived factor expression in glioma progression.
Guan M; Yam HF; Su B; Chan KP; Pang CP; Liu WW; Zhang WZ; Lu Y
J Clin Pathol; 2003 Apr; 56(4):277-82. PubMed ID: 12663639
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
[TBL] [Abstract][Full Text] [Related]
16. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
17. Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value.
Zhao WH; Yuan HY; Ren XY; Huang K; Guo ZY
Adv Clin Exp Med; 2019 Sep; 28(9):1179-1183. PubMed ID: 31414734
[TBL] [Abstract][Full Text] [Related]
18. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
[TBL] [Abstract][Full Text] [Related]
19. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
[TBL] [Abstract][Full Text] [Related]
20. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
